These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36974830)

  • 1. Effect of Adjuvant Systemic Chemotherapy on Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
    Yamaguchi N; Morizane S; Yumioka T; Shimizu R; Teraoka S; Iwamoto H; Hikita K; Honda M; Takenaka A
    Anticancer Res; 2023 Apr; 43(4):1725-1730. PubMed ID: 36974830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
    Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative risk classification for intravesical recurrence after laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma in a multi-institutional cohort.
    Somiya S; Kobori G; Ito K; Nakagawa H; Takahashi T; Koterazawa S; Takaoka N; Haitani T; Nagahama K; Ito M; Megumi Y; Higashi Y; Moroi S; Akao T; Yamada H; Kanno T
    Int J Urol; 2023 Oct; 30(10):853-858. PubMed ID: 37278493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma.
    Shigeta K; Kikuchi E; Hagiwara M; Ando T; Mizuno R; Abe T; Mikami S; Miyajima A; Nakagawa K; Oya M
    J Urol; 2017 Dec; 198(6):1278-1285. PubMed ID: 28634017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Early Intravesical Instillation of Epirubicin for Preventing Bladder Recurrence after Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma.
    Lee JH; Lee CU; Chung JH; Song W; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Sung HH
    Cancer Res Treat; 2024 Jul; 56(3):877-884. PubMed ID: 38271926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncological outcomes of radical nephroureterectomy for upper urinary tract urothelial neoplasia in Denmark.
    Azawi NH; Næraa SH; Subhi Y; Vásquez JL; Norus T; Dahl C; Thind P; Jensen JB
    Scand J Urol; 2020 Feb; 54(1):58-64. PubMed ID: 31942812
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.
    Yamashita S; Ito A; Mitsuzuka K; Ioritani N; Ishidoya S; Ikeda Y; Numahata K; Orikasa K; Tochigi T; Soma F; Namima T; Arai Y
    Jpn J Clin Oncol; 2017 Sep; 47(9):870-875. PubMed ID: 28903527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
    Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of post-void residual urine volume on intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sazuka T; Sakamoto S; Nakamura K; Imamura Y; Yamamoto S; Komiya A; Ichikawa T
    Int J Urol; 2019 Dec; 26(12):1106-1112. PubMed ID: 31522458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: a single institutional retrospective long-term follow-up study.
    Takaoka E; Hinotsu S; Joraku A; Oikawa T; Sekido N; Miyanaga N; Kawai K; Shimazui T; Akaza H
    Int J Urol; 2010 Jul; 17(7):623-8. PubMed ID: 20412341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of post-operative intravesical recurrence and oncological outcomes after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Zou L; Zhang L; Zhang H; Jiang H; Ding Q
    World J Urol; 2014 Apr; 32(2):565-70. PubMed ID: 24022234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
    Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical irrigation might prevent bladder recurrence in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Yamamoto S; Sakamoto S; Imamura Y; Sazuka T; Nakamura K; Inoue T; Chiba K; Miyazaki K; Inoue A; Nagata M; Ichikawa T
    Int J Urol; 2019 Aug; 26(8):791-796. PubMed ID: 31081198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
    Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
    J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract.
    Ishikawa S; Abe T; Shinohara N; Harabayashi T; Sazawa A; Maruyama S; Kubota K; Matsuno Y; Osawa T; Shinno Y; Kumagai A; Togashi M; Matsuda H; Mori T; Nonomura K
    J Urol; 2010 Sep; 184(3):883-7. PubMed ID: 20643446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and oncologic impact of chronic kidney disease for upper tract urothelial carcinoma in endemic area.
    Lee IW; Wang HJ; Liu HY; Chang YL; Wu YT; Chen YT; Cheng YT; Kang CH; Chuang YC; Luo HL
    J Formos Med Assoc; 2024 Jul; 123(7):758-763. PubMed ID: 38044211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
    Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.